Cargando…
May Women with a Negative Co-Test at First Follow-Up Visit Return to 3-Year Screening after Treatment for Cervical Intraepithelial Neoplasia?
Background: The Norwegian Cervical Cancer Screening Programme recommends that women treated for cervical intraepithelial neoplasia (CIN) only be returned to 3-year screening after receiving two consecutive negative co-tests, 6 months apart. Here we evaluate adherence to these guidelines and assessed...
Autores principales: | Skjeldestad, Finn Egil, Wergeland Sørbye, Sveinung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048535/ https://www.ncbi.nlm.nih.gov/pubmed/36981655 http://dx.doi.org/10.3390/ijerph20064739 |
Ejemplares similares
-
Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women—A cohort study
por: Westre, Bjørn, et al.
Publicado: (2019) -
Risk of Intraepithelial Neoplasia Grade 3 or Worse (CIN3+) among Women Examined by a 5-Type HPV mRNA Test during 2003 and 2004, Followed through 2015
por: Rad, Amir, et al.
Publicado: (2023) -
Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2016) -
5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions
por: Westre, Bjørn, et al.
Publicado: (2016) -
HPV mRNA Is More Specific than HPV DNA in Triage of Women with Minor Cervical Lesions
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2014)